Can Ocugen’s Conference Blitz Spark a Sustained Rally?

After an extended period of lateral trading, shares of biotechnology firm Ocugen are attracting renewed market interest. The catalyst appears to be a strategic push at several key industry conferences this month, prompting investors to question whether the company is finally approaching a pivotal transition.

Ocugen has embarked on an intensive schedule of investor presentations throughout October. The company recently presented at the “Cell & Gene Meeting on the Mesa” in Arizona. This is set to be followed by appearances at two additional high-profile events:
* Chardan’s 9th Annual Genetic Medicines Conference on October 21.
* The Maxim Growth Summit on October 22.

This concentrated series of appearances is a deliberate strategy. Under the leadership of CEO... Read more...